Pherecydes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pherecydes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pherecydes Today - Breaking & Trending Today

AKKADIAN PARTNERS SECURES THE APPOINTMENT OF A LEGAL EXPERT - AND REQUESTS CALLS ON ERYTECH TO DEFER THE VOTE ON THE MERGER WITH PHERECYDES UNTIL AFTER THE LEGAL EXPERT'S REPORT HAS BEEN SUBMITTED

Paris - June 15, 2023 - 7:30 am - In an Order dated June 14, 2023, the Summary Judgments Magistrate of the Commercial Court of Lyon ruled in favour of Akkadian Partners SA (hereafter "Akkadian") by ....

France General , Jean Leroux , Agence Calyptus , Bruggeman Mathieu Calleux , Summary Judgments Magistrate Of The Commercial Court , Ultra High Network Investors Uhnwis , Summary Judgments Magistrate , Commercial Court , Akkadian Partners , Abelia Consulting , General Meeting , Family Offices , Ultra High Network Investors ,

Pherecydes Pharma: Commercial Court Rejects Akkadian's Request to Postpone the Merger Vote: Pherecydes and Erytech Shareholders Will Be Able to Vote on the Merger on June 23, 2023

Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced today ....

Dusan Oresansky Nicolas Fossiez , Arthur Rouill , Erytech Pharma , Pherecydes Pharma , Lyon Commercial Court , Akkadian Pherecydes Pharma , Regulatory News , Lyon Commercial , Akkadian Partner , Oresansky Nicolas Fossiez ,

Erytech Pharma S.A.: ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma

ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA (U.S.) and Lyon (France), June 14 ....

United States , France General , United Kingdom , Nicolas Merigeau , Pherecydes Pharma , Enregistrement Universel , Pharma Bio , Eric Soyer , Mathilde Bohin Louis Victor Delouvrier , Exchange Commission , Company Securities , Company Annual Report On Form , Lyon Commercial Court , Commercial Court , Lyon Commercial , Akkadian Partner , Nasdaq Global Select Market , Next Biotech , Nasdaq Global Select , French Autorit , Des March , Registration Document , Annual Report ,

Akkadian Partners SA: Akkadian Suggests to Erytech an Alternative Strategy to its Merger with Pherecydes

Review of the true value of Erytech's assetsProposed strategy for ErytechAudit report requested by Akkadian stating the undervaluation of Erytechand the overvaluation of Phereceydes in the 1:1 parity adopted ....

France General , Mecklenburg Vorpommern , United States , Gil Beyen , Serono Genset , Eric Soyer , Agence Calyptus , Bruggeman Mathieu Calleux , Stefan Klotter , Francis Lefebvre , Nordic Society Of Paediatric Haematology , Ultra High Network Investors Uhnwis , Drug Administration , Security Exchange Commission , Akkadian Partners , Pharmium Securities , Journal Des , Nordic Society , Paediatric Haematology , Erytech General Meeting , Family Offices , Ultra High Network Investors , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips ,

Pherecydes Pharma: PHERECYDES Announces the Availability of the Exemption Document Relating to the Proposed Combination With Erytech Pharma

Regulatory News: PHERECYDES Pharma (FR0011651694 ALPHE), a biotechnology company specializing in extended phage therapy for treating antibiotic-resistant and/or complicated bacterial infections, announces ....

Gewinn Nur , Arthur Rouill , Pherecydes Pharma , Dusan Oresansky Nicolas Fossiez , Regulatory News , Erytech Pharma , General Meeting , Oresansky Nicolas Fossiez ,